Home
News
Create
Screeners
Insights
Medi Caps
24.
10
+0.41
(+1.73%)
Market Cap
₹30.01 Cr
PE Ratio
-6.77
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.73%
1M
-2.07%
6M
-36.58%
1Y
-43.82%
5Y
-37.56%
View Company Insights
Latest news about Medi Caps
Medi-Caps Limited Reports Q3FY26 Results with Contrasting Standalone and Consolidated Performance
Feb 11, 2026
Medi-Caps Limited announced mixed Q3FY26 financial results with standalone operations turning profitable at ₹28.50 lacs while consolidated performance showed losses of ₹76.58 lacs. The Board of Directors approved these results on February 11, 2026, highlighting strong recovery in real estate division through shop sales at Medi-caps Business Park, contrasted by ongoing challenges in the pharma division operated through subsidiary Medgel Private Limited.
Medi-Caps Limited Reports Mixed Financial Performance for Q2 and H1 FY2026
Nov 13, 2025
Medi Caps Limited Reports Q1 Loss, Schedules AGM and Announces Board Changes
Aug 05, 2025
Medi-Caps Limited Re-appoints Dharmendra Solanki as Independent Director for Second Term
Aug 05, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO